Organisationsprofil
Præsentation
Aims and objectives
The aim is "optimal pathology answers for the benefit of the patient"
The optimal pathology answer is of high diagnostic quality, timely, and contributes to the patients overall treatment
The optimal pathology answer ensures the future of patient care and technological development in addition with research of high national and international level.
Focus areas
Research in basic pathological areas including molecular characterization with focus on precision medicine.
Several molecular pathological studies are routinely performed on tissue and/or cell material from patients with colorectal cancer, breast cancer, melanoma, gynaecological cancer, haematological cancer and other malignant diseases - area where molecular analysis along with the classic pathology is a prerequisite for choosing the right treatment. In addition research in benign disorders is also conducted.
Furthermore the department focus on bio banking and includes the secretary for "Patobank" and "Regionernes Bio - og GenomBank (RBGB)".
Disciplines, methods and tools
The disciplines are traditional pathological methods such as immunohistochemistry and other molecular based analyses such PCR and hybridization techniques which include, as examples, various mutation analysis, methylation analysis, miRNA analysis, several different sequencing techniques, FISH, ISH and CISH.
Next generation sequencing (NGS) has been implemented as routine and cover both targeted sequencing as well as exome sequencing. Presently, implementation of digitalisation for reading/storing FISH and immunohistochemical data are on-going.
Fingerprint
Samarbejde og topforskningsområder i de sidste fem år
Profiler
Publikation
-
A Unified Machine Learning Model for Relapse Prediction in Clinical Stage I Testicular Cancer
Wagner, T., Marandi, R. Z., Lauritsen, J., Murray, D. D., Bandak, M., Grønkær Toft, B., Berney, D. & Daugaard, G., 2026, (Accepteret/In press) I: Andrology.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
-
Benefit of adjuvant chemotherapy in patients with T1a-bN0, triple-negative breast cancer – A systematic review and meta-analysis
Hassing, C. M. S., Juhl, C. B., Tvedskov, T. H. F., Nielsen, D. L., Knoop, A. S., Kroman, N. T., Lænkholm, A. V. & Kümler, I., maj 2026, I: Critical Reviews in Oncology/Hematology. 221, 105225.Publikation: Bidrag til tidsskrift › Review › peer review
-
Clinicopathological and Molecular Characterization of High Grade Endometrial Carcinomas of No Specific Molecular Profile (NSMP) Stratified by ER Status
Timmermans, P. T., Leon-Castillo, A., Kramer, C., Ter Haar, N., Smit, V., Boennelycke, M., Hogdall, E., Hogdall, C., Creutzberg, C. L., Horeweg, N., Ortoft, G. & Bosse, T., 1 jan. 2026, I: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 45, 1, s. 1-8Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
1 Citationer (Scopus)
Aktiviteter
- 2 Andet (priser, ekstern undervisning samt andet). - Andet
-
Vejledning af ph.d. studerende: Investigation of Tetranectin´s value as a part of a diagnostic index and as a predictive marker of postoperative complications and survival in Danisk ovarian tumor patients
Person, U. (Deltager)
2010Aktivitet: Andet › Andet (priser, ekstern undervisning samt andet). - Andet
-
Phd.-vejleder for Farah Diba Begum
Høgdall, E. V. S. (Deltager)
2007 → 2010Aktivitet: Andet › Andet (priser, ekstern undervisning samt andet). - Andet